A novel volatile anesthetic formulation for treating wounds or inflammation and methods of use. An effective amount of a volatile anesthetic such as isoflurane, halothane, enflurane, and sevoflurane dissolved in an aqueous solution, and dimethyl sulfoxide, N-methyl-2-pyrrolidone, dimethylformamide, dimethylacetamide, and ethanol for reducing volatility. A solution containing a solvent such as soybean oil, a composition that is a component of an emulsion containing lipids such as olive oil, and a composition having a surface, subarachnoid, epidural, transdermal, surface, oral, intraarticular, mucosal, Methods for administration by the oral, rectal, vaginal, intramuscular, intravesical and subcutaneous routes. [Selection diagram] Fig. 1【課題】創傷または炎症を処置する新規揮発性麻酔薬製剤及び使用法の提供。【解決手段】水溶液に溶解した有効量のイソフルラン、ハロタン、エンフルラン、セボフルラン等の揮発性麻酔薬と揮発性を低減させるためのジメチルスルホキシド、N-メチル-2-ピロリドン、ジメチルホルムアミド、ジメチルアセトアミド、エタノール等の溶媒を含む溶液が、ダイズ油、オリーブ油等の脂質を含む乳剤の成分である組成物、及び組成物を表面、くも膜下、硬膜外、経皮、表面、経口、関節内、粘膜、口腔、直腸、膣、筋肉内、膀胱内、および皮下の経路により投与する方法。【選択図】図１
